Drugs / tafluprostin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03595865 | Aug 2018 → Oct 2019 | glaucoma | wangdabo | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tafluprostin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03595865 ↗ |